ARTICLE | Company News
Aphios, Louisiana State University deal
March 23, 2009 7:00 AM UTC
Aphios received exclusive, worldwide rights to the university's IP covering pharmaceutical compositions of bryostatin-1, a modulator of protein kinase C activity. Aphios has an unnamed bryostatin-1 c...